Measuring telomere length is scientifically meaningful at the group level, but yields a number of limited practical use for an individual. Existing consumer tests measure an average in blood, while biological ageing is determined by the shortest telomeres in specific tissues. Research in this area is still at an early stage, and standardised protocols are lacking.
Telomeres are the protective 'caps' at the ends of chromosomes and grow shorter as cells divide and people age. They are therefore considered a potential measure of biological ageing. But measuring them is more complicated than it sounds, and what you can do with the result is limited.
The most widely used measurement method is qPCR: relatively inexpensive and scalable, suitable for large studies. The drawback is that qPCR yields only an average relative length, not the shortest telomeres at each chromosome end. That is a meaningful gap, because cellular ageing is determined precisely by the shortest telomeres, not the average. Newer methods such as TeSLA and a recently developed nanopore technique ('Telomere Profiling') do measure the shortest telomeres, sometimes even per chromosome end at near-nucleotide resolution. Length differences of more than six kilobases can exist between these methods. These more precise methods are not yet available as consumer products.
An added complication is that the measurement result depends strongly on how the sample was collected and stored. The sample type (blood, saliva, buccal mucosa), storage before and after DNA extraction, and the laboratory protocol used all influence the outcome. International standardisation is still lacking. Two measurements of the same person in different laboratories can therefore diverge, which makes comparability difficult.
Most commercially available telomere tests measure telomeres in blood. A meta-analysis of 55 studies (4,324 individuals, 102 tissues) shows that the correlation between blood telomeres and telomeres in other organs is moderate (r=0.58). In other words: what your blood indicates is not necessarily representative of what is happening in your brain, heart or intestinal tissue. Blood telomere length is recognised as a dynamic marker of biological health that reflects both genetic predisposition and lifestyle, but it is not a definitive diagnosis and not a direct reflection of specific organs.
Added to this is the fact that a portion of your telomere length is genetically fixed. Research using the nanopore method shows that the ranking of which chromosome end is relatively long or short is already established at birth and remains stable as telomeres shorten with age. Your telomere length therefore also says something about your hereditary predisposition, not just your lifestyle.
Yet telomere length is not meaningless as a biomarker. In studies of specific conditions, such as severe HPV-related precursors of cervical cancer, the combination of telomere length, telomerase activity and HPV typing in smears shows a distinguishing pattern. And combined with genetic methods (such as Mendelian randomisation), blood telomere length can provide insight into individual disease risk. But that is a research tool, not a self-test that already delivers clinically actionable individual recommendations. For a consumer who buys a test today, the following applies: the result provides a rough indication, but the interpretation is uncertain and comparability over time is not guaranteed as long as protocols are not standardised.
Based on multiple scientific publications (2009-2024), including a meta-analysis of 55 studies. The studies are predominantly associative in design; causal conclusions are not possible. No RCTs are available for diagnostic value. Commercial interests in consumer tests were not assessed in the underlying studies.